Spyglass Pharma Inc (SGP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2001 | 12-2000 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 2,716,000 | 2,397,000 |
| Marketable Securities | 75,000 | N/A |
| Receivables | 1,789,000 | 1,413,000 |
| Inventories | 945,000 | 951,000 |
| Income taxes - deferred | 573,000 | N/A |
| TOTAL | $6,519,000 | $5,720,000 |
| Non-Current Assets | ||
| PPE Net | 3,814,000 | 3,362,000 |
| Intangibles | 660,000 | 627,000 |
| Other Non-Current Assets | 1,181,000 | 1,096,000 |
| TOTAL | $5,655,000 | $5,085,000 |
| Total Assets | $12,174,000 | $10,805,000 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 565,000 | 994,000 |
| Accounts payable and accrued liabilities | 1,075,000 | 1,031,000 |
| Accrued Expenses | 343,000 | 312,000 |
| TOTAL | $3,917,000 | $3,645,000 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 830,000 | 827,000 |
| TOTAL | $1,132,000 | $1,041,000 |
| Total Liabilities | $5,049,000 | $4,686,000 |
| Shareholders' Equity | ||
| Shares Outstanding, K | 1,465,888 | N/A |
| Common Shares | 1,015,000 | 1,015,000 |
| Retained earnings | 10,849,000 | 9,817,000 |
| Other shareholders' equity | -423,000 | -318,000 |
| TOTAL | $7,125,000 | $6,119,000 |
| Total Liabilities And Equity | $12,174,000 | $10,805,000 |